Medtronic Recalls Some Insulin Pumps Over Cybersecurity Concerns
The company and FDA say certain pumps are vulnerable to hacking
Read More
Diabetes
Myocardial Perfusion PET Predicts Cardiac Death in Diabetes
Increasing magnitude of stress myocardial perfusion abnormality tied to cardiac death risk in diabetes
Read More
Higher Intake of Linoleic Acid May Reduce Type 2 Diabetes Risk
Risk down particularly when linoleic acids replace saturated fats, trans fats, or carbohydrates
Read More
Diabetes Outcomes Similar Regardless of Primary Provider
No difference in outcomes seen with care by physician, nurse practitioner, physician assistant
Read More
Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use
Anxiety and type 2 diabetes related to frequent visits to ED, high costs but not total hospitalization costs
Read More
Risk Factors ID’d for Atrial Fibrillation With Type 1 Diabetes
Risk factors for developing atrial fibrillation similar to those seen for other forms of cardiovascular disease
Read More
T2DM Risk in Offspring Up With Maternal Overweight, Obesity
Offspring of women who are overweight or obese during pregnancy have higher risk for type 2 diabetes
Read More
Late-Life Diabetes Status Tied to New Cognitive Impairment
Diabetes in late life with poor glycemic control, longer duration linked to incident cognitive impairment
Read More
Pediatric T1DM Medication Adherence Drops on Weekends, Holidays
Clinical characteristics, socioeconomic status, adverse effects do not predict adherence
Read More
American Diabetes Association, June 7-11
The American Diabetes Association 79th Scientific Sessions The annual meeting of the American Diabetes Association was held from June 7 to 11 in San Francisco and attracted approximately 14,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances in diabetes research and […]
Read More
ADA: Combo Injectable Controls Blood Glucose Longer in T2DM
Findings seen for initial injectable therapy with insulin degludec plus liraglutide versus insulin glargine
Read More
ADA: Teplizumab Can Delay T1DM Progression in Those at Risk
Median time to type 1 diabetes diagnosis 48.4 months with teplizumab and 24.4 months with placebo
Read More
In Most Older Adults, Prediabetes Stays Stable or Improves
One-third of participants progressed to diabetes or died within the 12-year follow-up
Read More
Conference Highlights: ADA 2019
New research was presented at ADA 2019, the 79th Scientific Sessions of American Diabetes...
Read More
ADA: Dulaglutide Tied to Decline in Cardiovascular Events in T2DM
Second study shows reduction in renal outcomes with dulaglutide in type 2 diabetes
Read More
Fewer New T2DM Cases Seen in Adults on Plant-Based Diet
Intake of vitamins B2, B6 linked to reduced risk for T2DM; B12 intake from food linked to higher risk
Read More
Irregular Sleep Patterns May Increase Risk for Metabolic Syndrome
Odds higher in two cross-sectional, prospective analyses after adjustment for sleep-related factors
Read More
ADA: Vitamin D Supplementation Does Not Lower T2DM Risk
No significant difference in risk for type 2 diabetes seen for those receiving vitamin D, placebo
Read More
Midlife Type 2 Diabetes May Up Later Risk for Cerebral Infarction
Genetic, early-life familial environmental factors seem not to contribute to link
Read More
No Evidence of Legacy Effect Seen for Intensive Glucose Lowering
Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes
Read More